ARS Pharmaceuticals (SPRY) Return on Sales (2022 - 2026)
ARS Pharmaceuticals (SPRY) reported Return on Sales of 0.04% for Q1 2026, little changed on a YoY basis from 0.04% in Q1 2025, and down 172.06% sequentially from 0.02% in Q4 2025.
ARS Pharmaceuticals (SPRY) Return on Sales (2022 - 2026) Analysis & Trends
ARS Pharmaceuticals (SPRY) has 5 years of Return on Sales data on file, last reported at 0.04% in Q1 2026.
- For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.04%; the trailing twelve-month figure through Mar 2026 stood at 0.05% (down 3.0% YoY), and the FY2025 full-year result was 0.02%, down 2.0% from the prior year.
- Return on Sales fell to 0.04% in Q1 2026, from 0.02% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.01% in Q4 2024 to a low of 53762.25% in Q1 2024.
- A 5-year average of 10219.12% and a median of 0.42% in 2022 frame the typical range for Return on Sales.
- Across the five-year window, Return on Sales tumbled 3820065 bps in 2023 and soared 5376220 bps in 2025, its largest moves.
- Tracing SPRY's Return on Sales over 5 years: stood at 0.42% in 2022, then slumped by 7366698 bps to 31026.2% in 2023, then jumped by 100 bps to 0.01% in 2024, then plunged by 385 bps to 0.02% in 2025, then slumped by 172 bps to 0.04% in 2026.
- Business Quant data shows SPRY's Return on Sales at 0.04% in Q1 2026, 0.02% in Q4 2025, and 0.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.00% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 0.00% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - | -0.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.14% |
| Mar 31, 2025 | -0.05% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | -0.75% |
| Jun 30, 2024 | -1.35% |
| Mar 31, 2024 | -53,762.25% |
| Dec 31, 2023 | -31,026.20% |
| Sep 30, 2023 | -31,027.90% |
| Jun 30, 2023 | -38,200.95% |
| Mar 31, 2023 | -19,703.62% |
| Dec 31, 2022 | -0.42% |
| Sep 30, 2022 | -0.80% |
| Jun 30, 2022 | -0.29% |
| Mar 31, 2022 | -0.17% |